Narayan Prabhu's Form 4 filing
Reviva Pharmaceuticals Holdings, Inc. (RVPH) · filed Jun 30, 2022
- Accession no.
- 0001437749-22-016306
- Filed
- Jun 30, 2022
- Trade date
- Jun 30, 2022
- Filing delay
- Same day
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 1 non-derivative transaction and 0 derivative transactions. Open-market purchases total $60.5K. It was filed on the trade date.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Narayan PrabhuCIK 0001829831 | Officer (Chief Financial Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 30, 2022 | Common Stock, par value $0.0001 per share | PPurchaseAcquired | +50,000 | $1.21 | +$60,500 | 50,000 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.